Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Administrative Core
Regulation of Vascular Smooth Muscle Cell Phenotype by a Novel Isoform of Glucose-6-Phosphate Dehydrogenase
A National Curriculum in Cancer Genomics for Pathology Residents
The Western diet and O-GlcNAc modification of chromatin proteins
Determinants of Cancer Risk and Outcome in Gi Oncology
Recently added grants:
Intrarenal B cells in acute kidney allograft rejection
Formation of the HIV-1 Latent Reservoir
Macrophage mitochodrial reprogramming and innate immune memory
Regulators of VSG allelic exclusion and switching in Trypanosoma brucei
Novel molecular mechanism of macrophage polarization in sepsis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07159-20-0-1
Application #
7574908
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ University of Texas Sw Medical Center Dallas
$905,218
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
Rogers, Zora R. /
$616,542
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant